Example: Heart Attack

Clinical Trials on Kasabach-Merritt Syndrome

Total 6 results

    • NCT03188068
      Recruiting
      Sirolimus Plus Propranolol Versus Sirolimus Plus Prednisolone for Kaposiform Hemangioendothelioma
      Conditions: Kaposiform Hemangioendothelioma; Kasabach Merritt Phenomenon
    • NCT04448873
      Recruiting
      Guided Discontinuation Versus Maintenance Treatment of Sirolimus in Pediatric Patients With Kaposiform Hemangioendothelioma
      Conditions: Kaposiform Hemangioendothelioma; Kasabach-Merritt Syndrome
    • NCT04409691
      Not yet recruiting
      SCMC Trial on KHE With KMP (V.2020)
      Conditions: Kaposiform Hemangioendothelioma (KHE) With Kasabach-Merritt Phenomenon (KMP)
    • NCT02110069
      Active, not recruiting
      A Study to Compare Vincristine to Sirolimus for Treatment of High Risk Vascular Tumors
      Conditions: Kaposiform Hemangioendothelioma (KHE); Kasabach-Merritt Syndrome; Tufted Angioma
    • NCT04077515
      Recruiting
      Safety and Efficacy of Low-dose Sirolimus to Kaposiform Hemangioendothelioma
      Conditions: Hemangioma; Kaposiform Hemangioendothelioma
    • NCT04056962
      Recruiting
      Tacrolimus for the Treatment of Superficial Kaposiform Hemangioendothelioma and Tufted Angioma
      Conditions: Tacrolimus, Kaposiform Hemangioendothelioma, Tufted Angioma
      Medical Conditions
      Sponsors and Collaborators
      Drug Interventions
      Conditions
      Rare Diseases
      Drug Interventions
      Dietary Supplements
      Sponsor/Collaborators
      Locations